Agilent Has Built an Annuity on Merck’s Clinical Programme, One Indication at a Time
Agilent won its eighth CE-marked companion diagnostic indication for a single PD-L1 assay, each one riding on a label expansion Merck paid to generate.
The Beats
Analysis
The Briefs
Agilent Has Built an Annuity on Merck’s Clinical Programme, One Indication at a Time
China Approved the World’s First Once-Daily Oral Factor B Inhibitor, and a US Small-Cap Licensed It a Month Early
Accord’s Denosumab Biosimilars Launch With Cigna Preferred Status Already Secured
One Robot, Three Ways In: Momentis Clears Multiport a Day After J&J Shrank the Footprint
A Company Called StrokeDx Just Cleared a Device That Is Not Cleared to Detect Stroke